zidovudine has been researched along with Peripheral Nerve Diseases in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.82) | 18.7374 |
| 1990's | 20 (58.82) | 18.2507 |
| 2000's | 5 (14.71) | 29.6817 |
| 2010's | 6 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clifford, DB; Haas, DW; Johnson, DH; Leger, PD; Li, J; McLaren, PJ; Robbins, GK; Shafer, RW | 1 |
| Gilks, CF; Kikaire, B; Kiwuwa-Muyingo, S; Levin, JB; Mambule, I; Musana, H; Musoro, G; Walker, AS | 1 |
| Ananworanich, J; Bennett, K; Chomchey, N; DeGruttola, V; Ebenezer, G; Gerschenson, M; Hauer, P; Hongchookiat, P; Jadwattanakul, T; Mathajittiphun, P; McArthur, JC; Nakamoto, B; Phanuphak, N; Phanuphak, P; Praihirunkit, P; Shikuma, CM; Teeratakulpisarn, N | 1 |
| Birbal, S; Dheda, M; Ojewole, E; Oosthuizen, F | 1 |
| Benki-Nugent, SF; Chung, MH; Etyang, A; John-Stewart, GC; Kohler, PK; McGrath, CJ; Njoroge, J; Thiga, JW | 1 |
| Ananworanich, J; Chomchey, N; Gerschenson, M; Hongchookiat, P; Jadwattanakul, T; Kerr, SJ; Kim, JH; Mathajittiphun, P; Phanuphak, N; Phanuphak, P; Pinyakorn, S; Praihirunyakit, P; Rungrojrat, P; Shikuma, C; Teeratakulpisarn, N; Valcour, V | 1 |
| Mukai, E | 1 |
| Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N | 1 |
| Arenas-Pinto, A; Bhaskaran, K; Dunn, D; Weller, IV | 1 |
| Auclair, C; Beaulieu, R; Boulerice, F; Gill, J; Montaner, JS; Phillips, P; Rachlis, A; Schindzielorz, A; Schlech, W; Smaldone, L | 1 |
| Ramcharitar, S; Simpson, DM; Tagliati, M | 1 |
| Mintz, M | 1 |
| Miller, RG | 1 |
| Antoniskis, D; Arezzo, J; Bigley, J; Bozzette, SA; Fischl, MA; Gelb, LD; Gocke, DJ; Grieco, MH; Hirsch, MS; Hyslop, NE; Leedom, JM; Lim, L; LoFaro, ML; McKinley, GF; Merigan, TC; Murphy, RL; Pettinelli, CB; Pottage, JC; Powderly, WG; Ray, G; Reed, N; Richman, DD; Schaumburg, HH; Simon, G; Skowron, G; Soo, W; Spector, SA; Sperber, SJ; Uttamchandani, RB; Zachary, J | 1 |
| Carr, A; Penny, R | 1 |
| Gazzard, BG; Hawkins, D; Moyle, GJ; Nelson, MR | 1 |
| Brew, BJ; Currie, JN; McArthur, JC; Wright, EJ | 1 |
| Authier, FJ; Gherardi, RK; Lefaucheur, JP; Verroust, J | 1 |
| Brew, BJ; Markus, R | 1 |
| Moyle, GJ; Sadler, M | 1 |
| Cohen, P; Gayraud, M; Gherardi, R; Guillevin, L; Jarrousse, B; Leon, A; Lhote, F | 1 |
| Cross, A; Dunkle, L; Kelleher, T | 1 |
| Conant, M | 1 |
| Aramideh, M; Koelman, JH; Koopmans, RP; Stam, J | 1 |
| Cruz-Sánchez, FF | 1 |
| Martin, ES; Rathbun, RC | 1 |
| Keilbaugh, SA; Prusoff, WH; Simpson, MV | 1 |
| Bozzette, SA; Fraser, A; Hayden, E; Jacobsen, C; Richman, DD; Santangelo, J; Schnack, J; Spector, SA; Villasana, D; Wright, B | 1 |
| Allan, JD; Canetta, R; Connolly, KJ; Fitch, H; Groopman, JE; Jackson-Pope, L; McLaren, C | 1 |
| Simpson, DM; Wolfe, DE | 1 |
| Dalakas, M; Sever, J; Wichman, A | 1 |
| Berg, G; Dalakas, M; Fischl, M; Grafman, J; Klecker, RW; McAtee, N; Perno, CF; Thomas, RV; Wichman, A; Yarchoan, R | 1 |
| Hartung, HP; Heininger, K; Toyka, KV | 1 |
11 review(s) available for zidovudine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
[Neuromuscular diseases associated with HIV-1 infection].
Topics: Anti-HIV Agents; Cytomegalovirus Infections; HIV Infections; Humans; Neuritis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Zalcitabine; Zidovudine | 2004 |
Neurologic complications of AIDS: new concepts and treatments.
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Brain Diseases; Humans; Muscular Diseases; Nervous System Diseases; Peripheral Nervous System Diseases; Spinal Cord Diseases; Zidovudine | 1994 |
Clinical comparison of adult and pediatric NeuroAIDS.
Topics: Adult; Age Factors; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; Atrophy; Biomarkers; Central Nervous System; Child; HIV Infections; HIV-1; Humans; Peripheral Nervous System Diseases; Zidovudine | 1994 |
Neuromuscular complications of human immunodeficiency virus infection and antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Humans; Peripheral Nervous System Diseases; Zidovudine | 1994 |
Roundtable discussion: management issues in didanosine therapy.
Topics: Didanosine; Dose-Response Relationship, Drug; Health Personnel; HIV Infections; Humans; Occupational Exposure; Pancreatitis; Peripheral Nervous System Diseases; Zidovudine | 1993 |
Managing HIV. Part 5: Treating secondary outcomes. 5.4 HIV-induced neurological disease.
Topics: AIDS Dementia Complex; Antiviral Agents; Brain Diseases; HIV Infections; Humans; Nervous System Diseases; Peripheral Nervous System Diseases; Zidovudine | 1996 |
Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management.
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1998 |
Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Data Collection; Didanosine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Polypharmacy; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Zalcitabine; Zidovudine | 1999 |
[Peripheral nerve diseases and myopathies associated with HIV infection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; HIV Infections; Humans; Muscular Diseases; Peripheral Nervous System Diseases; Polyneuropathies; Polyradiculopathy; Zidovudine | 2000 |
AIDS and the nervous system.
Topics: Acquired Immunodeficiency Syndrome; Adult; Central Nervous System Diseases; Dementia; Humans; Male; Nervous System Diseases; Neuromuscular Diseases; Opportunistic Infections; Peripheral Nervous System Diseases; Zidovudine | 1989 |
[Neuromuscular manifestations of HIV-1 and HTLV-I infections].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adrenal Cortex Hormones; Capsaicin; Carbamazepine; Demyelinating Diseases; Ganciclovir; HIV-1; HTLV-I Infections; Humans; Muscular Diseases; Neuritis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Polyneuropathies; Zidovudine | 1988 |
10 trial(s) available for zidovudine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Topics: Adolescent; Adult; Aged; Anti-Retroviral Agents; Antitubercular Agents; Didanosine; Female; HIV Infections; Humans; Incidence; Isoniazid; Male; Middle Aged; Peripheral Nervous System Diseases; Prevalence; Risk Factors; Stavudine; Uganda; Young Adult; Zidovudine; Zimbabwe | 2014 |
Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Leg; Male; Peripheral Nervous System Diseases; Risk Factors; Sensory Receptor Cells; Skin; Stavudine; Tenofovir; Thailand; Zidovudine | 2015 |
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Diet; Drug Administration Schedule; Drug Substitution; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Peripheral Nervous System Diseases; Stavudine; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Patient Compliance; Peripheral Nervous System Diseases; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2008 |
The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial.
Topics: Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Zalcitabine; Zidovudine | 2008 |
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematologic Diseases; HIV Core Protein p24; Humans; Leukocyte Count; Male; Peripheral Nervous System Diseases; Weight Gain; Zalcitabine; Zidovudine | 1993 |
Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Data Collection; Didanosine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Polypharmacy; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Zalcitabine; Zidovudine | 1999 |
Peripheral nerve function in persons with asymptomatic or minimally symptomatic HIV disease: absence of zidovudine neurotoxicity.
Topics: Acquired Immunodeficiency Syndrome; Adult; HIV; Humans; Male; Neurons, Afferent; Peripheral Nervous System Diseases; Placebos; Zidovudine | 1991 |
Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; AIDS-Related Complex; Didanosine; Drug Evaluation; Female; Hemoglobins; Humans; Hypocalcemia; Male; Pancreatitis; Peripheral Nervous System Diseases; Zidovudine | 1991 |
Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Clinical Trials as Topic; Dementia; Humans; Male; Middle Aged; Paraplegia; Peripheral Nervous System Diseases; Thymidine; Time Factors; Zidovudine | 1988 |
14 other study(ies) available for zidovudine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Case-Control Studies; Drug Combinations; Drug Therapy, Combination; Genome-Wide Association Study; Genotype; Humans; Lamivudine; Multicenter Studies as Topic; Peripheral Nervous System Diseases; Polymorphism, Genetic; Principal Component Analysis; Randomized Controlled Trials as Topic; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Adverse drug reactions associated with antiretroviral therapy in South Africa.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Exanthema; Female; Gynecomastia; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Nevirapine; Peripheral Nervous System Diseases; Renal Insufficiency; Retrospective Studies; South Africa; Stavudine; Tenofovir; Zidovudine | 2016 |
Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Incidence; Kenya; Male; Peripheral Nervous System Diseases; Probability; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2012 |
Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment Program.
Topics: Adult; Amylases; Cause of Death; Cohort Studies; Didanosine; Drug Evaluation; Female; Follow-Up Studies; HIV Infections; Humans; Male; Pancreatitis; Peripheral Nervous System Diseases; Prospective Studies; Risk Factors; Safety; Survival Analysis; Treatment Failure; Zidovudine | 1994 |
The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT)
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Complex; Body Weight; Diarrhea; Didanosine; Female; HIV Core Protein p24; Humans; Leukocyte Count; Lymphocyte Subsets; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases; Quality of Life; Risk Factors; Zidovudine | 1993 |
Zidovudine and human immunodeficiency virus-associated peripheral neuropathies: low intake in patients with mononeuropathy multiplex and no evidence for neurotoxicity.
Topics: Acquired Immunodeficiency Syndrome; Adult; HIV Infections; Humans; Peripheral Nervous System Diseases; Retrospective Studies; Zidovudine | 1997 |
HIV-1 peripheral neuropathy and combination antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Peripheral Nervous System Diseases; Saquinavir; Zidovudine | 1998 |
Successful treatment of HIV-related vasculitis with peripheral neuropathy with short-term steroids followed by the association of zidovudine and plasmapheresis.
Topics: Adult; AIDS-Related Opportunistic Infections; Combined Modality Therapy; HIV Seropositivity; Humans; Male; Peripheral Nervous System Diseases; Plasmapheresis; Prednisone; Prospective Studies; Vasculitis; Zidovudine | 1993 |
New antiretroviral strategies: interview with Marcus Conant, M.D. Interview by John S. James.
Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; HIV; HIV Infections; Humans; Isoquinolines; Lamivudine; Peripheral Nervous System Diseases; Protease Inhibitors; Quinolines; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1995 |
Rapidly progressing peripheral neuropathy with lactic acidosis and coproporphyria in a patient with HTLV-I associated T-cell leukaemia treated with zidovudine.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Disease Progression; Female; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Mitochondria; Peripheral Nervous System Diseases; Porphyrias; Zidovudine | 2001 |
[Human immunodeficiency virus infection and neurological changes].
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Brain Diseases; Central Nervous System Diseases; Cognition Disorders; HIV-1; Humans; Nervous System Diseases; Peripheral Nervous System Diseases; Risk Factors; Zidovudine | 1992 |
Didanosine therapy in patients intolerant of or failing zidovudine therapy.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Didanosine; Female; HIV Core Protein p24; Humans; Leukocyte Count; Male; Peripheral Nervous System Diseases; Retrospective Studies; Time Factors; Treatment Failure; Zidovudine | 1992 |
The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs.
Topics: Animals; Axons; Bone Marrow; Cell Division; Cell Line, Transformed; Didanosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Peripheral Nervous System Diseases; Stavudine; Tumor Cells, Cultured; Zalcitabine; Zidovudine | 1991 |
Neuromuscular complications of HIV infection and its treatment.
Topics: Adrenal Cortex Hormones; Demyelinating Diseases; HIV Infections; Humans; Myositis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Zidovudine | 1991 |